Earnings Call Insights: Nektar Therapeutics (NKTR) Q1 2026 Management view “Supported by these results, we're moving quickly to initiate the ZENITH-AD Phase III program in patients with moderate to severe atopic dermatitis by July of this year.” (CEO, President & Director Howard W. Robin) “We expect to have the first data from the Phase III program in mid-2028 and this will support our goal of sub...
Earnings Call Insights: Nektar Therapeutics (NKTR) Q1 2026 Management view “Supported by these results, we're moving quickly to initiate the ZENITH-AD Phase III program in patients with moderate to severe atopic dermatitis by July of this year.” (CEO, President & Director Howard W. Robin) “We expect to have the first data from the Phase III program in mid-2028 and this will support our goal of submitting a BLA in 2029.” (CEO, President & Director Robin) “In April, we announced positive 52-week top line results from the blinded treatment extension period in the Phase II REZOLVE-AA study.” (CEO, President & Director Robin) “We plan to initiate the Phase III program in alopecia areata in the first part of 2027 to add a second potential indication to Nektar's BLA submission for REZPEG.” (CEO, President & Director Robin) “Since year-end, we've raised approximately $783 million in net proceeds through 2 financings.” (CEO, President & Director Robin) “We ended the first quarter of 2026 with $731 million in cash and this does not include our April financing, which adds another $350 million to our balance sheet bringing total cash and investments today to over $1 billion.” (CEO, President & Director Robin) “We ended the first quarter of 2026 with $731.6 million in cash and investments with no debt on our balance sheet.” (Interim Chief Financial Officer Sandra Gardiner) Outlook “We expect to end 2026 with approximately $800 million to $825 million in cash and investments.” (Interim Chief Financial Officer Gardiner) “We do, however, expect R&D expense to increase on a quarterly basis in 2026 as these Phase III clinical studies are initiated.” (Interim Chief Financial Officer Gardiner) “Our planned registrational program called ZENITH-AD is expected to include 3 trials in total.” (Senior VP and Chief Research & Development Officer Jonathan Zalevsky) “We expect the first data readout from the Phase III program in the middle of 2028.” (Senior VP and Chief Research & Development O...
Christian Mueller-Glissmann, managing director for portfolio strategy and asset allocation at Goldman Sachs, discusses risk appetite amid US efforts to end the war in Iran. "A lot of the clients we speak to do very little in terms of taking a view on that conflict," Mueller-Glissmann tells Bloomberg Television. "They rather try to do tweaks and twists to the portfolio and focus on diversification....
Christian Mueller-Glissmann, managing director for portfolio strategy and asset allocation at Goldman Sachs, discusses risk appetite amid US efforts to end the war in Iran. "A lot of the clients we speak to do very little in terms of taking a view on that conflict," Mueller-Glissmann tells Bloomberg Television. "They rather try to do tweaks and twists to the portfolio and focus on diversification." (Source: Bloomberg)
Guido Mieth/DigitalVision via Getty Images The following segment was excerpted from The London Company Small Cap Portfolio Q1 2026 Commentary . The London Company Small Cap portfolio decreased 1.8% (-2.0% net) during the quarter vs. a 0.9% increase in the Russell 2000 Index. Both sector exposure and stock selection were headwinds to relative performance. Top 3 Contributors to Relative Performance ...
Guido Mieth/DigitalVision via Getty Images The following segment was excerpted from The London Company Small Cap Portfolio Q1 2026 Commentary . The London Company Small Cap portfolio decreased 1.8% (-2.0% net) during the quarter vs. a 0.9% increase in the Russell 2000 Index. Both sector exposure and stock selection were headwinds to relative performance. Top 3 Contributors to Relative Performance Matson, Inc. ( MATX ) – MATX was the top performer as container shipping rates strengthened amid supply chain disruptions and management executed on operational efficiency initiatives. Strong pricing power in the Hawaii trade lane and improving West Coast logistics drove margin expansion. The company's disciplined capital allocation, including share buybacks at attractive valuations, reinforced our confidence in management's ability to generate shareholder value through the cycle. UniFirst Corporation ( UNF ) – UNF was a positive contributor as the board of directors reached an agreement with Cintas to be acquired for a premium above the prior trading price. In response to that news, the stock rallied. We anticipate the merger will be completed but acknowledge that there are potential antitrust issues that could prolong deal timelines. Acushnet Holdings Corp. ( GOLF ) – GOLF delivered strong returns from steady golf participation and premium brand resilience amidst operational headwinds and mixed results. Inventories are healthy and the company is well positioned for planned product launches later this year. We believe that the company continues to benefit from the secular growth of golf while appealing to the dedicated golfer who remains recession resilient. Top 3 Detractors from Relative Performance Revolve Group, Inc ( RVLV ) – RVLV sold off as the online fashion retailer faced softer consumer demand and lower discretionary spending. While near-term headwinds around discretionary spending created volatility, we remain confident in the company due to its premium-priced re...
MACOM Technology Solutions (NASDAQ:MTSI) reported fiscal second-quarter 2026 revenue of $289 million and adjusted earnings per diluted share of $1.09, supported by what management described as strong demand across its three end markets and a record backlog. President and CEO Steve Daly said sequent
MACOM Technology Solutions (NASDAQ:MTSI) reported fiscal second-quarter 2026 revenue of $289 million and adjusted earnings per diluted share of $1.09, supported by what management described as strong demand across its three end markets and a record backlog. President and CEO Steve Daly said sequent